Cloning and Characterization of New emm Allele of Streprococcus pyogenes Strains Isolated in Kingdom of Saudi Arabia
Magdy M. Mohamed
In the present study, 39 isolates of erythromycin-resistant group A Streptococcus (GAS) isolated in the kingdom of Saudi Arabia from 2003 to 2004 were characterized by using phenotypic and genotypic methods. Most strains (94.9%) had similar or highly related pulsed-field gel electrophoresis profiles to different nine emm types previously documented. In which, type emm1 was the most prevalent M type in KSA representing 20.5% of total isolates, followed by emm3 (15.4%) typing. Two new emm sequence types were identified among GAS strains designated SA15 and SA37. The type SA15 carried two resistant mefA and ermTR genes accounted for 6.3% (1/16) and 50.0% (1/2), respectively. Entire fragment of SA15 was sequenced and expressed in expression vector to be used as a tool for vaccine preparation in this area. This report provides information on new emm sequence types firstly detected in KSA GAS isolates as a vaccine candidate antigen in this geographic area which not extensively surveyed, also it contributes to a better understanding of the local and global dynamics of GAS populations and the epidemiological aspects of GAS infections occurring in KSA.
Streptococcus pyogenes is one of the most common and ubiquitous human pathogens and is a significant leading cause of human morbidity worldwide. It is responsible for a wide range of infections in areas where the diseases are endemics or epidemics (Stevens, 2000) with varying from clinically mild infections (pharyngitis, impetigo, scarlet fever, etc.), to severe life-threatening infections (sepsis, necrotising fasciitis, toxic shock syndrome with muli-organ failure), or non-suppurative sequelae such as rheumatic fever, rheumatic heart disease and acute glomerulonephritis (Stevens, 2000). In the late 1980s, reports on the resurgence of severe Streptococcus pyogenes frequently referred to as group A streptococci (GAS) infection (Hoge et al., 1993) resulted in an increased awareness and interest in this organism.
Most of knowledge that has been accumulated concerning GAS epidemiological
studies is based on traditional methods of T-agglutination typing (T-typing)
and M-precipitation typing (M-typing) that have been used in for many years
(Efstrtiou, 2000). The M protein, a cell surface protein, (M-typing), is an
important virulence determinant in the pathogenesis of suppurative and non-suppurative
diseases (Praksachatkunakorn et al., 1993) and it is responsible for
the antigenic variations which is a basis for serological typing method (Facklam
et al., 1999). More than 80 different GAS M types have been identified
by serological M typing, however, many GAS isolates are nontypeable due to the
lack of appropriate type specific antisera or loss of antigen expression (Praksachatkunakorn
et al., 1993; Pruksakorn et al., 2000). In recent years DNA sequencing-based
methods for characterizing GAS strains have been used including sequence analysis
of emm gene-specific PCR products (emm typing) of M protein gene
that permits the typing of strains which cannot be serologically classified
(Beall et al., 1996 and 1997). This methodology has allowed the recognition
of several previously unknown GSA types in different geographic areas, demonstrating
the usefulness of emm typing for detecting genetic diversity among GSA
isolates and tracing GSA infection. Approximately 150 M protein gene sequence
types (emm) of GAS have been documented (Fica et al., 2003). Some
types have seemed to be associated with certain patterns of disease more frequently
than others. Historically, types such as M1, M2, M3, M4, M12, M15, M49, M55,
M56, M59, M60 and M61 have been associated with post-streptococcal glomerulonephritis,
while types M5, M6, M18, M19 and M24 have been linked to rheumatic fever (Bisno,
2001). More recently, types M1 and M3 were also epidemiologically associated
with the resurgence of some severe forms of GAS infections, such as toxic shock
syndrome and necrotizing fasciffis (Ho et al., 2003). A few studies have
described the distribution of GAS types mainly in Western countries where the
epidemiology of GAS may be different. Studies from Malaysia and Thailand, where
rheumatic fever is endemic, have indeed a different GAS type distribution in
this region (Kaplan et al., 2001; Kim and Lee, 2004).
Although penicillin is the drug of choice for the treatment of S. pharyngitis (Betriu et al., 1993), an increased failure of this treatment due to copathogenicity with β-lactamase-producing microorganisms has been reported (Coleman et al., 1993). In these cases and in cases where patients are allergic to penicillin, other antibiotics not subject to inactivation by β-lactamases as amoxicillin-clavulanate, oral cephalosporins, or erythromycin, have been substituted for penicillin (Betriu et al., 1993). Resistance to erythromycin remained at low levels among S. pyogenes in most countries of the world, however, in the last years a significant increase in erythromycin-resistant isolates in many development countries has been reported (Alberti et al., 2003; Cornaglia et al., 1996; Martin et al., 2002; Seppala et al., 1992). Where the erythromycin resistance frequency has increased to more than 16% in the last 10 years, reaching 40% in some regions of Asia (Kaplan et al., 1992; Pruksakrn et al., 2000). Therefore, epidemiologically and genetically investigations of different and prevalent M protein types in erythromycin resistance S. pyogenes causing diseases in local and other parts of the world communities is necessary for formulation and development of a suitable vaccine.
In vaccine development, many studies have defined protective epitopes from the N-terminal and C-terminal regions of the M protein (Brandt et al., 1997 and 2000). So identification of predominant M types in certain area would facilitate the development of a vaccine targeted to such population. However, the vast number of isolates from specific regions of endemicity remain largely uncharacterized, with over 80% of isolates being classified as non-M typeable (Kaplan et al., 1992; Kim and Lee, 2004), have not yet been characterized (Kim and Lee, 2004). Actually, effective vaccines against GAS would be based upon complex combinations of specific types of M protein components. The formulations for these vaccines would requite knowledge of the types of GAS causing disease in different communities (Kaplan et al., 1992; Brandt et al., 1997). Recently a vaccine presently under investigation and undergoing clinical trials contains 26 different specific emm types of M protein fragments (Hu et al., 2002). A similar approach is being used to formulate a vaccine based upon prevalent GAS M protein types observed in the Australian aboriginal population (Brandt et al., 2000). It has been estimated that the aforementioned 26-valent vaccine (26VV) represents 78 to 80% of the type distribution seen in pharyngitis and invasive-infection GAS isolates in the United States (Hu et al., 2002). The potential coverage of this 26VV for strains causing infections in other parts of the world is unknown.
The objective of the present study was to characterize of GSA M type isolates belonging to erythromycin resistant strains in patients living in KSA for epidemiological studies. These data provide useful information about the prevalent and new emm isolates of GAS in KSA, that identified and expressed in a suitable vector to be used in further studies as a vaccine domain.
MATERIALS AND METHODS
Strains: A total of 107 GSA isolates produced beta-hemolytic colonies were randomly collected from 3 different hospital-based laboratories, geographically distributed in different areas in KSA between 2004 to April 2005. Among them 39 erythromycin resistant isolates from different patients infected with S. pyrogenes were selected in this study, other samples were eliminated because they were also resistant to other antimicrobial agents. Five strains were blood isolates whereas the remaining strains were throat swabs isolates. Swabs were cultured on blood agar plates, with incubation period at 37°C in CO2 incubator for 24 to 48 h. All GSA isolates were stored in glycerol stocks (Gherna, 1981) at -80°C until required.
Susceptibility tests and determination of erythromycin resistance phenotypes: MICs of penicillin, erythromycin, tetracycline and clindaroycin (Sigma Chemical Co., St. Louis, Mo.) were determined by the agar dilution method according to the recommendations of the NCCLS (NCCLS, 2000). Resistance phenotypes of erythromycin-resistant isolates were determined by the disk tests (Becton Dickinson, Cockeysville, Md.) as described previously (Seppala et al., 1997). The breakpoint used for erythromycin resistance was <1 mg mL-1.
DNA isolation: The organisms were streaked out on blood agar plates and a single colony was used to inoculate 50 mL of Todd-Hewitt broth. After incubation at 37°C overnight, the culture was spun down and the pellet was washed three times with phosphate-buffered saline (PBS; pH 7.0), resuspended in 0.5 mL of a lysozyme solution (100 mg mL-1) and incubated at 37°C for 1 h. Sodium dodecyl sulfate (200 μL of a 20% solution) and Proteinas K (100 μL of a 10 mg mL-1 solution) were added and the suspension was incubated at 55°C overnight. One-third volume of a saturated NaCl solution was added and the mixture was incubated at 4°C for 20 min. The mixture was then centrifuged to sediment the protein, the supernatant was transferred to a new tube and 95% ethanol (3 volumes) was added to precipitate the DNA. The tube was rocked gently until the DNA flocculated. The DNA was then washed once in 70% ethanol and retrieved with a bent-tip pipette, allowed to air dry for 1 min, resuspended in 0.5 mL of Tris-EDTA buffer (pH 7.8) and stored at 4°C until used.
PFGE analysis: Analysis of DNA was carried out by pulsed-field gel electrophoresis (PFGE) analysis by following standard procedures. Briefly, DNA was digested with 10 U of smaI (New Eggland Biolabs, Beverly, Mass.), restricted DNA fragments were separated in 1% agarose gel in 0.5X tris-EDTA buffer by using a CHEF-DRIll apparatus (Bio-Rad Laboratories, Barcelona, Spain). Electrophoretic pulses were linearly distributed from 20 to 70 sec for a run time of 22 h. The voltage was 6 V/cm and the temperature of the electrophoresis chamber was kept at 14°C. The gels were stained with ethidium bromide and photographed. The interpretation of restriction fragment patterns was performed in accordance with recent consensus publications (Tenover et al., 1995).
Detection of antibiotic resistance genes by PCR: PCR was performed with a volume of 50 μL containing 4 μL of (5 mM) deoxynucIcoside triphosphate mixture, 5 μL of 10X reaction buffer, 0.2 μL (1 U) of Taq polymerasc, 2.5 μL (20 pmol) of each primer, 2 μL of streptococcal genomic DNA and sufficient double-distilled water for the 50 μL total volume. In the thermal reactor, 95°C for 7 min, followed by a total of 35 cycles, comprising denaturation at 95°C for 30s, annealing at 55°C for 1 min and synthesis at 72°C for 1.5 min, were carried out. Sequence of primers used were previously described (Jasir et al., 2001) for detection of erythromycin resistance genes (ermA, ermB, mefA and ermTR). The expected sizes of PCR products were 208 for ermA, 640 bp for ermB, 350 bp for mefA and 530 bp for ermTR. The PCR products were separated by electrophoresis in a 1% agarose gel, stained with ethidium bromide and photographed with Polaroid film under UV light.
PCR and sequencing analysis of emm gene (emm-typing):
The emm gene type of S. pyogenes isolates was determined by amplification
and sequencing of the emm gene as described previously by Beall et
al. (1999). The forward primer, 5'CAGTATTMMAGAAAATTAAA A3 was derived
from leader sequence of the M protein gene (Martin et al., 2002). The
antisense primer, 5'CCCTTACGGCTTGCTTCTGA3, was derived from the C repeat
region of the M protein gene, which is conserved in several GAS isolates (Martin
et al., 2002). These primers were used in PCR and for cycle sequencing.
PCR was done as described above. The product was purified by using the Qia Quick
PCR purification kit (Qiagcn) as described by the manufacturer. emm sequence
was performed directly from the purified product using 6 μL of product
per reaction, 4 μL of M forward primer, 8 μL of premix for the ABI
310 automated sequencer, as described by the manufacturers instruction.
The sequences obtained were subjected to homology searches with the nucleotide
sequences against all known emm sequence of streptococcal M proteins
in the GenBank in the National Institutes of Health DNA database with BLASTN
(Altschul et al., 1997).
emm Restriction Profiling (ERP) analysis: To compare isolates within the same serological M type, the emm genes were subjected for restriction endonucleases cleavage analysis as previously documented methods (Facklam et al., 2002).
Protein expression: For expression of the encoded protein, the PCR fragment was recovered and digested with EcoRI and BamHI and ligated into pGEX4T-1 vector. Following transformation of E. coli JMI09 competent cells, ampicillin resistant colonies were examined by the cracking gel method to identify colonies with recombinant plasmid. Plasmid DNA was prepared from a positive colony. Orientation and reading frame were verified by sequencing. A single bacterial colony containing the plasmid pGEX-4T-1 was grown in culture and induced with 0.5 mM IPTG. Cells were harvested at 1 h intervals by centrifugation at 3000xg and resuspended in fusion protein extraction buffer (Tris-HCI, 50 μLM; NaCl, 15 mM; EDTA, pH 8.5; Triton-X l.00, 1%; PMSF, l mM). Cells were then lysed by sonication for 2-3 min at 20 Khz with 30 sec intervals using 0.2 nm rnicrotipe and centrifuged in a sorvall SS34 rotor at 12000 rpm at 4°C for 10 min. The pellet was then resuspended in the fusion protein extraction buffer and aliquots of the whole unfractionated lysate, supernatent and pellet were analyzed for proteins on 15% SDS PAGE gels (Laemmli, 1970).
Antimicrobial susceptibility: Overall, 4.7% of isolates (5 of 107) were
intermediately resistant and 31.8% of isolates (34 of 107) were fully resistant
to erythromycin, as determined by the disk diffusion method. The five erythromycin-intermediate
isolates were examined further by determination of the MICs. The erythromycin
MICs for all five isolates were in the resistant range (MIC 1 to 4 μg mL-1).
|| PFGE profiles of SmaI digested genomic DNAs from 39
erythromycin resistant S. pyogenes M types
||1% gel electrophoresis for emm gene polymorphism tests
of 2 un-typed KSA isolates SA15, in lanes 2 and 4 digested with Hind
III and SA37, in lanes 3 and 5 digested with Mbo II restriction
enzymes cleavage respectively. Lane 1 is molecular weight marker, (1kbp
DNA ladder; Gibico)
PCR analysis for erythromycin resistance genes was performed for the 39 erythromycin-resistant
isolates. Of these, 17 isolates (43.6%) had the ermA gene alone, 14 (35.9%)
had the mefA gene alone and 2 (5.1%) had both the ermTR gene and
the mefA gene. The remaining six isolates (15.4%) had the ermB
gene alone. The five isolate that had intermediate results in the disk diffusion
test all possessed the ermA gene as represented in Table
Gene diversity and PFGE: A genomic characterization was carried out
by genomic DNA macrorestriction with SmaI and PFGE representing profiles
of 39 erythromycin-resistant S. pyrogenes isolates as shown in Fig.
1. Visual and computerized analysis of the SmaI patters revealed
11 different unrelated patterns, where more than two band difference between
two patterns was used as a criterion to define a PFGE type (Beall et al.,
|| Erythromycin resistant gene determinants by PCR for 39 isolates
|a Two strains were positive for both ermTR
and mefA, N.D non determined genotypes
Nine PFGE patterns were previously documented patterns representing (94.9%)
among these isolates and remaining two patterns (one isolate each) were unidentified
(5.1%). The most prevalent PFGE pattern of the total 39 erythromycin resistant
isolates in KSA in this study was represented as pattern D with 8 (20.5%) isolates
and pattern G with 6 (15.4%) isolates. A limited clonal heterogeneity was characterized
by the identification of these different pulsotypes.
ERP analysis: Among 39 strains tested, PFGE showed two different patterns. Isolates SA15 and SA37 were further genotyping characterization by ERP analyzed by using two different restriction enzymes; HindIII and MboII as demonstrated in Fig. 2. Three major bands were invariably present with different molecular weights.
Distribution and prevalent emm genes: The 39 different strains
mentioned above were subjected to emm gene sequencing. A total of 9 different
M types were found in the 37 invasive and noninvasive isolates Overall, 37 (94.9%)
of 39 S. pyogenes clinical isolates included in this study had 5' emm
sequences ≥95% identical to the first 160 bases of one of the emm
or emm-like genes deposited in GenBank. For most of these sequences,
31/37 (83.8%) isolates showed a high level of identity to the sequence of M
types which actually extended from 200 to 450 bases without base mutation.
||Nucleotide sequence and deduced amino acid sequence for SA15
clone. The coding nucleotide sequence is shown in the upper case. The start
codon ATG is the first condon
The sequences of other 6 (16.2%) isolates were ≥95% identical to the sequence
of standard M type reference strain emm genes with a point mutation or
frameshift for up to five amino acids. The remaining 2 of 39 (5.1%) isolates
had an undocumented emm gene sequence. This sequence was provisionally
designated as SA15 that was only 85% identical to the emm28 and SA37
that was only 89% similar sequence over the first 160 bases of emm49
type. Different identified emm genes were represented in Table
emm1, emm3, emm12 and emm9 were the most prevalent emm sequences among S. pyrogenes isolates susceptible to erythromycin (Table 1). In descending order of frequency, they accounted 8/37 (21.6%) for M1, 6/37 (16.2%) for M3, 5/37 (13.5%) for M12 and 4/37 (9.4%) for M9, respectively, of these isolates. These four M types together 23/37 accounted for 62.2%. Besides these prevalent emm sequences, the following most common sequences 14/37 (37.85) were emm4, emm6, emm28, emm44 and emm75, each type of which accounted for approximately ≤8% of the erythromycin-susceptible isolates. Three M types (M1, M4 and M12) were the most prevalent isolates from noninvasive group (throat swaps). While, M9 was common in the invasive group (blood isolates) and noninvasive isolates, M28 type was absent from the invasive isolates. Type M44 was more frequent in the invasive isolates than in the noninvasive isolates overall (2 of 5 versus 1 of 32; p<0.0001).
Sequence analysis of SA15 and its expression: Remarkably, only two new
sequence type was found among the 39 isolates. A complete codoning sequence
was carried out for SA15 gene from both sides, the nucleotide sequence and deduced
amino acids were represented in Fig. 3. It was found that
SA15 (from a pharyngitis patient) shared 85% sequence identity of amino acid
sequence with the previously described emm28 (GenBank accession number
AF091805; Fig. 4a). It shows only about 60% identity over
its predicted N-terminal 180 amino acid residues and 64% over its predicted
C-terminal 80 amino acid residues. SA37 shows 89% similarities over its predicted
amino acid residues for M49 (Fig. 4b). The deduced SA15 sequence
sharing very little similarity to other known M proteins within the type-specific
region (roughly residues 18 to 92), while sharing a strong similarity within
its partial signal sequence (residues 1 to 18) and residues 93 to 240 with corresponding
sequences of many other GAS emm genes (a comparison with its best overall
match with emm28 type deduced peptide sequence is shown in Fig.
4a). SA15 differs from M28 in the presence of an additional sixty amino
acid residues at the N terminus of the mature protein and a 29-amino-acid deletion.
Complete sequence of SA15 was carried out in order to cloned in expression vector
and expressed it as a protein for vaccine studies.
In order to study the characteristics of SA15 protein, the coding sequence
was subcloned in the expression vector pGEX4T-1 and the protein was expressed
in E. coli as a fusion protein with Sj26.
||Alignment of amino acid sequence of SA15 of GAS isolate with
M28 amino acid sequence (derived from GenBank), showing 85% homology, X
represents missing amino acids, dashes are missing amino acids
||Alignment of amino acid sequence of SA37 of GAS isolate with
M49 amino acid sequence (derived from GenBank), showing 89% homology, X
represents missing amino acids
||SDS-PAGE for lysate from induction experiment of clone SA15
in the expression vector pGEX4T-1. Lanes 1-9 show induction 30 min time
intervals, lanes 10, 11 show pellet lysate of last two samples, lane 12
is a prestained molecular weight marker; Gibco)
Five hours post induction of pGEX-SA15 bacterial cell lysates, resuspended
pellet of lysed cells and supernatant were run on 15% SDS-PAGE. The protein
was present mostly in the total cell lysate and in the supernatant fraction.
Figure 5 shows a band of ~ 66 kDa, thus the expected size
for a protein of ~ 40 kDa fused with Sj26.
Resistance to macrolids, avocated for GAS infection primarily in case of beta-lactam
allergy or intolerance, has been reported from many countries following overuse
or abused of these drugs (Seppala et al., 1992). Recently, in KSA erythromycin
is used in the treatment of many diseases as chlamydial, respiratory tract and
mycoplasmal infections rather than streptococcal infections so the rate of consuming
this drugs is increasing leading to evoke a new generation of microorganisms
that resist to erythromycin antibiotics. Therefore, the rate of erythromycin
resistance among Saudi GAS clinical isolates appeared comparatively high 39/107
(36.4%), compared with reported rates of 2.1 to 4.6% in Canada (Weiss et
al., 2001), 2.6% in the United States (Ho et al., 2003; Green et
al., 2005), 8.6% in Finland (Seppala et al., 1993) and 1.8% in Sweden
(Jasir et al., 2001). Present findings are similar to the overall rate
in Italy 25.9% (Cornagila et al., 1996). The pattern of resistance phenotypes
in erythromycin-resistant GAS strains in Sweden was markedly decreased (from
12 to 1.8%) of both macrolide consumption and level of erythromycin resistance
(Martin et al., 2002). A relation between occurrence of the different
macrolide resistance phenotypes and total consumption of macrolide antibiotics
therefore appears conceivable. The high rates of resistance that found in KSA
are probably a reflection of the high level of antibiotic usage in this community,
which has also brought about high macrolide resistance rates in pneumococci
(Chiu et al., 2001).
The erythromycin resistance phenotypes of the 39 erythromycin-resistant isolates were determined by disk test. Thirty-seven (94.9%) isolates were of the erythromycin-resistant M phenotype, 2 (5.1%) isolates were of the constitutive erythromycin-resistant non M phenotype. Genetic determinants of erythromycin resistance were investigated in all erythromycin-resistant isolates by means of PCR experiments with specific primer sets for ermA, ermB, ermTR and mefA. As predicted, all 39 resistant isolates carried one or more of these resistant genes. The resistance genotypes might show a different chronological distribution. The positive isolates of ermA and mefA were predominant. Genetic diversity was found among the mefA positive isolates, which revealed six PFGE different patterns corresponding to different six emm genotyping. Only two unique PFGE patterns were obtained for the 16 mefA positive isolates, while other 14 (35.9%) showed four distinct PFGE pattern (Fig. 1 and Table 1). However, 17 (43.6%) of the 39 patients were ermA positive isolates and showed four different patterns. Other six isolates (15.4%) were ermB-positive isolates showed only one pattern of PFGE. Thus, the predominance of mefA was in part due to the prevalence of a genetically related clone (Betriu et al., 1993).
This study found that the majority of strains with more than one isolate were
isolated from both throat and blood sites. However, types (M1, M4 and M12) were
the most prevalent isolates from patients with pharyngeal diseases which were
commonly found in noninvasive disease isolates (Jasir et al., 2000).
Despite this finding, type M1 was disproportionately represented in invasive
and pharyngeal isolates, as has been reported elsewhere (Jasir et al.,
2000). Previous studies suggested that a virulent of M1 clone was responsible
for the majority of severe GAS infections that have occurred since the mid-1980s
(Jasir and Schalen, 1998). Although type M3 has been reported to be prevalent
in the United States, Canada and other countries (Davies et al., 1996),
particularly for invasive isolates, this M type was second prevalent type observed
in the present studying in both invasive and noninvasive isolates (6/37; 16.2%)
after type M1 (8/37; 21.6%). As suggested by Green et al. (2005) whom
showed that the major invasive types, M1 and M3, were equally prevalent in pharyngeal
isolates where pharyngeal infections may have served as a reservoir for virulent
GAS clones (Kaplan et al., 2001; Johnson et al., 2002). Furthermore,
the M1 and M3 isolates causing invasive infections had PFGE patterns that were
identical to those of concurrent pharyngeal isolates. These published results
are in agreement with our observations that invasive M1 isolates and noninvasive
M1 isolates shared identical PFGE profiles. Moreover emm4 strains were
isolated in Spain, Finland and Great Britain (Seppala et al., 1993 and
1997; Alberti et al., 2003) as the erythromycin-resistant type and accounted
for 20% of the GAS resistant to erythromycin which accounted only less than
6% in present study.
In addition, there was also an increase in severe forms of GAS infection during the mid-1990s (Tang et al., 2001). Meningitis, necrotizing fasditis and toxic shock syndrome due to many unknown GAS types. These data revealed that the recent appearance of these severe forms of disease is probably a reflection of changes in the epidemiology of the prevalent M types. The rapid introduction of new strains into a population is well documented (Viaminckx et al., 2005). Therefore, the introduction and dissemination of streptococcal strains with enhanced virulence potential are plausible explanations for this increase in severe forms of infection and are compatible with the disproportionate representation of type M1 in the throat and invasive isolate. Although recent studies involving a comparison of a large number of invasive isolates with control strains, there was no evidence of an association between a particular clone and invasive infection (Pruksakorn et al., 2000; Kaplan et al., 2001; Green et al., 2005).
Antigenic variations in the M proteins compared to published sequences were predominantly due to single base substitutions, small deletions and insertion in the 50 N-terminal residues of hypervariable region representing several new alleles (Beall et al., 1997). Previous studies revealed that a number of M family groups showed compensatory frameshift mutations, as in cases of emm55, emm53, emm80, emm5, emm49, emm13, emm33 and emm70 (Beall et al., 1997). The translated sequences of the M proteins of isolates under investigation that corresponding to M1, M3, M4, M9, M12 and M75 showed complete homology in the hypervariable region. However, M44, M28 and M6 isolates were differed in sequence by point mutations in the hypervariable region with no more than three amino acid substitutions that predicting a new alleles for those M proteins. This study also showed that the GAS type distribution in KSA might be different from those in Thailand and Malaysia (Pruksakorn et al., 2000). In the latter two countries, acute rheumatic fever is still an important health problem, but in KSA this disease has been seen very rarely in the last 20 years. Nonetheless, the serotype distribution in any population is in constant flux (Weiss et al., 2001; Green et al., 2005). Besides serotype distribution, GAS disease epidemiology is also subject to influence from ethnic, cultural and socioeconomic factors (Kim and Lee, 2004; Sagar et al., 2004).
Indeed, the percentage of isolates from patients in Brazil, New Guinea Gambia, Ethiopia and Malaysia with new emm gene sequences is much higher than the percentage of such isolates found in this study and certain European countries (Kaplan et al., 1992; Coleman et al., 1993; Lopardo et al., 2005). These recent findings are consistent with a previous statement maintaining that there is a higher percentage of M-nontypeable strains from Africa than from Britain (Coleman et al., 1993). Sequence analysis of the 39 isolates used in this study revealed 2 novel-sequence M types of erythromycin resistance among GAS isolates. One exhibited such novel phenotype carried both ermB and mefA erythromycin resistant genes. The combination of these determinants has only been detected in Italian GAS isolates (Cornaglia et al., 1996) and was not identifiable with other published emm sequences. This finding shows the diversity of GAS strains found in KSA. These two novel emm sequence type, SA15 and SA37, was found in an isolate from patients with pharyngitis. The SA15 sequence type differs from M28, described previously, at two regions in the 5' hypervariable region. Other SA37 isolate shows low homology to M49 (89%) that exhibited a frameshift mutations.
M sequence typing is a useful tool for conducting epidemiological studies of streptococcal infections, particularly in an area where many GAS isolates are non-M typeable by conventional M serotyping methods. It allows not only monitoring of streptococcal carriage within regions of endemicity but also identification of types of circulating Streptococci that provides a useful guideline for developing a vaccine in specific area of endemicity. This study indicates that the M protein type distribution within a diverse set of GAS clinical isolates recovered from KSA during 2003 to 2004 is similar to the types distribution found within U.S. invasive GAS isolates (Kaplan et al., 1992). In fact, a current 26VV formulated for usage within the United State (Hu et al., 2002) would theoretically be effective against 64% of the 37 GAS isolates described here, which represent 7/11 of the M types included in this vaccine. It must be noted here that the type emm4 isolates (which were the fifth most frequently occurring pharyngeal isolates in this study) together with other two new nontypeable emm genes have not been included in this vaccine. Nonetheless, component(s) within the 26VV did elicit bactericidal antibodies against one new type emm 28 isolates tested (Hu et al., 2002).
To achieve the maximum coverage of multivalent, M type-based vaccines within
individual countries or regions in the world, different formulations would be
based upon specific emm sequence types predominant for these areas. Such
determinations would optimally entail multiyear surveillance, since changes
in serotype distributions do occur over extended time periods and in local communities
(Espinosa et al., 2003; Sagar et al., 2004) very rapid shifts
in M type can occur within the same pharyngitis season (Espinosa et al.,
2003; Lopard et al., 2005). In addition, the data presented here were
not necessarily representative of the entire country of KSA. For these reasons,
we hope that emm typing- based surveillance is continued and expanded
to locations throughout KSA. Such surveillance would be important in evaluations
of the feasibility of multivalent M-based vaccines in KSA and would also be
required to monitor vaccine effects on GAS populations subsequent to vaccine
introduction. With vaccines targeted toward a subset of common M types, there
is the possibility that identified untypeable new emm genes in this study
and that with rarely occurring M types could increase in number. Although most
isolate collections have not been population based, it still appears that targeted
areas within Argentina (Lopard et al., 2005), Mexico (Espinosa et
al., 2003), Western Europe (Hollm-Delgado et al., 2005), Asia and
North Africa (Lopard et al., 2005; Viaminckx et al., 2005) share
extensive overlap in common emm type, distribution with the United States
(Kaplan et al., 1992; Brandt et al., 1997), which makes the concept
of multivatent M protein-based vaccines more attractive. However, predominant
emm types found in clinical isolates within specific areas of New Zealand
(Viaminckx et al., 2005), Australia (Brandt et al., 2000), Chile
(Martin et al., 2002), Malaysia, India (Sagar et al., 2004), Nepal,
Egypt and New Guinea overlap less extensively with common emm types found
in the United States (Brandt et al., 1997; Hu et al., 2002).
To the best of my knowledges, this study is the first report of the genotypes of GAS associated with erythromycin resistant strains in KSA. In conclusion, Nevertheless, in our area, the total level of erythromycin resistance among GAS is currently high, presumably resulting in increasing usage of macrolides in the treatment of respiratory tract infection. The results show that monitoring of GAS isolate diversity by emm gene typing is a useful approach for a better understanding of the epidemiology and origins of specific GAS strains and provide a basis for future studies on changes in the epidemiology of GAS, outbreak investigation and development of preventive measures and of recommendations for vaccine preparation and treatment strategies in KSA.
This study was partially supported by grants 1426 from the Department of Biology,
Kingdom of Saudi Arabia. I gratefully acknowledge the Laboratories Staff
member of National Hospitals whom supplied me with necessary tools and equipments.
I thank Dr. Mohamed M. Shohayeb, who provided the streptococcal isolates from
and helping me of revising the paper.
Alberti, S., C. Garcia-Rey, M.A. Dominguez, L. Aguilar, E. Cercenado, M. Gobernado and A. Garcia-perea, 2003. Survey of emm gene sequence from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility. J. Clin. Microbiol., 41: 2385-2390.
Altschul, S.F., T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller and D.J. Lipman, 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res., 25: 3389-3402.
PubMed | Direct Link |
Beall, B., R. Facklam and T. Thompson, 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A Streptococci. J. Clin. Microbiol., 34: 953-958.
Beall, B., R. Facklam and T. Thompson, 1999. Sequencing PCR products for routine and accurate typing of group A Streptococci. J. Clin. Microbiol., 34: 953-958.
Beall, B., R. Facklam, J. Elliott, A. Franklin and D. Jackson et al., 1998. Strcptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subgroup A strcptococci. J. Med. Microbiol., 47: 893-898.
Beall, B., R. Facklam, T. Hoenes and B. Schwartz, 1997. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyrogenes infection isolates collected in San Francisco, California; Attanta, Georgia and Connecticut in 1994 and 1995. J. Clin. Microbiol., 35: 1231-1235.
Betriu, C., A. Sanchez, M. Gomez, A. Cruceyra and J. Picazo, 1993. Antibiotic susceptibility of group A Streptococci: A 6-year follow-up study. Antimicrob. Agents Chemother., 37: 1717-1719.
Bisno, A.L., 2001. Nonsuppurative Poststreptococcal Sequelae: Rheumatic Fever and Glomerulonephritis. In: Principles and Practice of Infectious Diseases, Mandell, G.L., J.E. Bennett and R. Dolin (Ed.). Churchill Living Stone, Philadelphia, pp: 2117-2127.
Brandt, E.R., K.S. Sriprakash, R.I. Hobb, W.A. Hayman and W. Zeng et al., 2000. New multi-determinant strategy for a group a streptococcal vaccine designed for the Australian aboriginal population. Nat. Med., 6: 455-459.
Brandt, E.R., W.A. Hayman, B. Currie, S. Pruksakorn and M.F. Good, 1997. Human antibodies to the conserved region of the M protein: Opsonization of the heterologous strains of group A Streptococci. Vaccine, 15: 1805-1812.
Chiu, S.S., P.L. Ho, F.K. Chow, K.Y. Yuen and Y.L. Lau, 2001. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob. Agents Chemother., 45: 2765-2770.
Coleman, G., A. Tanna, A. Efstratiou and E.T. Gaworzewska, 1993. The serotype of Streptococcus pyogenes present in Britain during 1980-1990 and their association with diseases. J. Med. Microbiol., 39: 165-178.
Cornaglia, G., M. Ligozzi, A. Mazzariol, M. Valentini, G. Orefici and P. Fontana, 1996. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg. Infect. Dis., 2: 339-342.
Davies, H.D., A. MeGeer, B. Schwartz, K. Green, D. Cann, A.E. Simor and D.E. Low, 1996. Invasive group a streptococcal infections in Ontario, Canada. Ontario group a streptococcal study group. N. Engl. J. Med., 335: 547-554.
Direct Link |
Efstratiou, A., 2000. Group a Streptococci in the 1990. J. Antimicrob. Chemother., 45: 3-12.
Direct Link |
Espinosa, L.E., Z. Li, D.G. Barreto, E.C. Jaimes and R.S. Rodriguez et al., 2003. M protein gene type distribution among group a streptococcal clinical isolates recovered in Mexico City, Mexico, from 1991 to 2000 and Durango, Mexico, from 1998 to 1999: Overlap with type distribution within the United States. J. Clin. Microbiol., 41: 373-378.
Facklam, R.F., B. Beall, A. Efstratiou, V. Fischetti and D. Johnson et al., 1999. emm typing and validation of provisional M types for group A streptococci. Emerg. Infect. Dis., 5: 247-253.
Direct Link |
Facklam, R.F., D.R. Martin, D.R. Johnson, A. Efstratiou and T. Thompson et al., 2002. Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: Emm 103 to emm124. Clin. infect. Dis., 34: 28-38.
Direct Link |
Fica, A., J. Fernandez, G. Ebensperger, E. Cona and A. Galanti et al., 2003. Molecular epidemiology of a Streptococcus progenes related nosocomial outbreak in a burn unit. Rev. Med. Chil., 131: 145-154.
Gherna, R.L., 1981. Preservation. In: Manual of Methods for General Bacteriology, Gerhdrdt, P., R.G.E. Murray, R.N. Costilow, E.W. Nester, W.A. Wood, N.R. Krieg and G.B. Phillips (Eds.). American Society for Microbiology, Washington, DC., pp: 208-217.
Green, N.M., S.B. Beres, E.A. Graviss, J.E. Allison and A.J. McGeer et al., 2005. Genetic diversity among type emm 28 group A streptococcus strains causing invasive infections and pharyngitis. Clin. Microbiol., 43: 4083-4091.
Direct Link |
Ho, P.L., D.R. Johnson, A.W. Yue, D.N. Tsang, T.L. Que, B. Beall and E.L. Kaplan, 2003. Epidemiologic analysis of invasive and noninvasive group A streptococcal isolates in Hong Kong. J. Clin. Mcrobiol., 41: 937-942.
Hoge, C.W., B. Schwartz, D.F. Talkington, R.D. Breiman, E.M. MacNeill and S.L. Englender, 1993. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. J. Am. Med. Assoc, 269: 384-389.
Hollm-Delgado, M.G., R. Allard and P.A. Pilon, 2005. Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001. Emerg. Infect. Dis., 11: 77-82.
Hu, M.C., M.A. Walls, S.D. Stroop, M.A. Reddish, B. Beall and J.B. Date, 2002. Immunogenicity of a 26-valent group A streptococcal vaccine Infect. Immun., 70: 2171-2177.
Jasir, A. and C. Schalen, 1998. Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyrogenes. J. Antimicrob. Chemother., 41: 135-137.
Jasir, A., A. Tanna, A. Efstratiou and C. Scha1en, 2000. High rate of tetracycline resistance in Streptococcal pyrogenes in Iran: An epidemiological study. J. Clin. Microbiol., 38: 2103-2107.
PubMed | Direct Link |
Jasir, A., A. Tanna, A. Efstratiou and C. Schalen, 2001. Unusual occurrence of Mtype 77, antibiotic resistant group A streptococci in Southern Sweden. J. Clin. Microbiol., 39: 586-590.
Johnson, D.R., J.T. Wotton, A. Shet and E.L. Kaplan, 2002. A comparison of group A streptococci from invasive and uncomplicated infections: Are virulent clones responsible for serious streptococcal infections? J. Infect. Dis., 185: 1586-1595.
Kaplan, E.L., D.R. Johnson, P. Nanthapisud, S. Sirilertpanrana and S. Chumdempadetsuk, 1992. A comparison of group A streptococcal serotypes isolated from the upper respiratory tract in the USA and Thailand: Implications. Bull. WHO, 70: 433-437.
Kaplan, E.L., J.T. Wotton and D.R. Johnson, 2001. Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis. Lancet, 358: 1334-1337.
PubMed | Direct Link |
Kim, S. and N.Y. Lee, 2004. Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea. J. Antimicrob. Chemother., 54: 447-450.
Direct Link |
Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680-685.
CrossRef | Direct Link |
Lopardo, H.A., P. Vidal, M. Sparo, P. Jeric and D. Centron et al., 2005. Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina. J. Clin. Microbiol., 43: 802-807.
PubMed | Direct Link |
Martin, J.M., M. Green, K.A. Barbadora and E.R. Wald, 2002. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med., 346: 1200-1206.
Direct Link |
NCCLS., 2000. Methods for Dilution Anti-Microbial Susceptibity Tests for Bacteria That Grow Aerobically. 5th Edn., NCCLS, Wayne, PA.
Praksachatkunakorn, C., T. Vaniyapongs and S. Pruksakornn, 1993. Impetigo: An assessment of etiology and appropriate therapy in infants and children. J. Med. Assoc. Thail., 76: 222-229.
Pruksakorn, S., N. Sittisombut, C. Phornphutkul, C. Praksachatkunakorn, M. Good and F. Brandt, 2000. Epidemiological analysis of non-M-typeable group A streptococcal isolates from a Thai population in Northern Thailand. J. Clin. Microbiol., 38: 1250-1254.
Sagar, V., D.K. Bakshi, S. Nandi, N.K. Ganguly, R. Kumar and A. Chakraborti, 2004. Molecular heterogeneity among North Indian isolates of Group A Streptococcus. Lett. Applied Microbiol., 39: 84-88.
Seppala, H., A. Nissinen and P. Huovinen, 1993. Three different phenotypes of erythromyein-resistance in group A Streptococci in Finland. J. Antimicrob. Chemother., 32: 885-891.
Seppala, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager and P. Huovinen, 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med., 337: 441-446.
Seppala, I.L., A. Nissinen, I. jarvinen, S. Houvinen, T. Henriksson and E. Herva, 1992. Resistance to erythromycin in group A Streptococci. N. Engi. J. Med., 326: 292-297.
Stevens, D.L., 2000. Group A beta-hemolytic Streptococci: Virulence Factors, Pathogenesis and Spectrum of Clinical Infections. In: Streptococcal Infections; Clinical Aspects, Microbiology and Molecular Pathogenesis, Stevens, D.L. and E.L. Kaplan (Eds.). Oxford University Press, New York, pp: 19-36.
Tang, W.M., P.L. Ho, K.K. Fung, K.Y. Yuen and J.C. Leong, 2001. Necrotising fasciitis of a limb. J. Bone Joint Surg., 83: 709-714.
Direct Link |
Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing and B. Swaminathan, 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J. Clin. Microbiol., 33: 2233-2239.
Viaminckx, B.J., W. van Pelt and J.F. Schellekens, 2005. Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992-2003. J. Clin. Microbiol. Infect., 11: 564-568.
Weiss, K., J. De Azavedo, C. Restieri, L.A. Galarneau and M. Gourdeau et al., 2001. Phenotypic and genotypic characterization of macrolide-resistant group A streptococcus strains in the province of Quebec, Canada. J. Antimicrob. Chemother., 47: 345-348.